Early diagnosis is critical, as every 30-minute delay between symptoms and treatment increases the 1-year mortality rate by 7.5%.1
TnT Gen 5 STAT, an assay that aids in the diagnosis of myocardial infarction, has a negative predictive value of over 99% in just 3 hours which provides you the confidence to rule patients in - and out - faster.2,3
References: Troponin T Gen 5 STAT package insert 2017 , Siemens ADVIA Centaur and ATELLICA hsTnI package inserts 2018 (on file), Beckman Access and DxI hsTnI package inserts 2018 (on file)
* TnT Gen 5 satisfies the high sensitivity criteria on the cobas e 601 and e 602
TnT Gen 5 STAT is the FIRST highly sensitive troponin in US history.2,4
TnT Gen 5 STAT is the first FDA-cleared troponin assay to meet the IFCC recommendations4 for high sensitivity5 AND deliver optimal precision per the Fourth Universal Definition of Myocardial Infarction.6
TnT Gen 5 STAT provides clear advantages over other high sensitive troponin assays 2, 4, 8, 9
View Full TableTnT Gen 5 STAT provides clear advantages over other high sensitive troponin assays 2, 4, 8, 9
|
99th Percentile |
Time to result |
Rule out after two serial draws |
Standardized Sex Specific Cutoffs |
Global Launch Date |
US Launch Date |
Peer-reviewed articles |
|---|---|---|---|---|---|---|---|
Roche TnT Gen 5 STAT |
19 ng/L |
9 min. |
YES |
YES |
2009 |
2017 |
>900 |
Siemens ADVIA Centaur and ATELLICA hsTnI |
Not standardized |
18/10 min. Not standardized |
NO |
NO |
2017 |
2018 |
<50 |
Beckman Access and DxI hsTnI |
Not standardized |
17 min. |
YES |
NO |
2018 |
2018 |
<50 |
Abbott hsTnI |
None available |
||||||
Ortho hsTnI |
None available |
||||||
With TnT Gen 5 STAT, you’re backed by the most comprehensive educational offering in the industry:
Learn about evidence-based best practices and current care guidelines from cardiac subject matter experts.
Access insights and peer-to-peer support from the first adopters of TnT Gen 5 STAT.
Receive dedicated before-and-after sales support from our highly experienced, specialized teams.
References:
1. De Luca G., Suryapranata, H., Ottervanger, J.P., and Antman, E.M. (2004). Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction. Circulation 109:1223–1225.
2. Elecsys TnT Gen 5 STAT Package Insert, 2017.
3. As compared to previous generation troponin assays
4. TnT Gen 5 satisfies the IFCC high sensitivity criteria on the cobas e 601 and e 602
5. https://www.aacc.org/publications/cln/cln-stat/2015/april/16/new-guidance-on-high-sensitivity-cardiac-troponin-testing (Accessed 4/27/18)
6. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/08/24/00/09/fourth-universal-definition-of-mi-esc-2018 (Accessed 10/30/2018)
7. Tobias Reichlin, M.D., et al. (2009). Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. N Engel J Med 361:858-867. DOI: 10.1056/NEJMoa0900428
8. Siemens ADVIA Centaur and ATELLICA hsTnI package inserts 2018 (on file)
9. Beckman Access and DxI hsTnI package inserts 2018 (on file)
